A multimarker test based on stroma-related circulating molecules, combined with biomarkers that are related to the characteristics of tumor cells (e.g., CA-125, CEA, CA 15-3 CA19.9, TPS), is a promising platform for tumor diagnosis and to perform patients’ follow-up through blood analysis. Here, CEACAM5 is linked to neoplasm.